• Sarah M Yassin, Marius Terblanche, James Yassin, and Catherine A McKenzie.
• Institute of Pharmaceutical Sciences, Franklin-Wilkins Building, Kings College, London, SE1 7RT, UK; Pharmacy and Critical Care Guys and St Thomas' NHS Foundation Trust (GSTFT), St Thomas' Hospital, London, SE1 7EH, UK.
• J Crit Care. 2015 Apr 1;30(2):436.e1-6.

PurposeThe purpose of this work was to obtain a detailed perspective of sedation practice. Sedation included sedative and opioid choice, presence of local guidelines, and use of scoring systems.MethodsA Web-based survey was designed. The aim was to gain sufficient detail of UK sedation while also being succinct enough to complete in 15 minutes. It was composed of relevant demographics, policy, sedative choice, and analgesia. The survey was piloted before launch. The investigators selected the intensive care unit (ICU) pharmacist as the respondent.ResultsOne hundred fifty-seven ICUs responded. Eighty-nine (59%) reported use of sedation guidelines, 78% undertook sedation holds, and 87% use sedation scores. Only 42% used a daily sedation target. Seventy (43%) assess for delirium; 27 of those use a validated tool. Propofol (89%) use was common, followed by midazolam (49%). Morphine (49%), fentanyl (34%), and alfentanil (34%) were the most frequently used opioids.ConclusionThis survey confirmed expected variation in UK sedation practice. Recognized strategies such as target sedation score and sedation policy are underused. A 43% uptake in delirium screening suggests that larger engagement is required to meet national standards.Copyright © 2014 Elsevier Inc. All rights reserved.

36 keywords...

hide…